Maher Albitar
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 152
- Acute Myeloid Leukemia Research 77
- Chronic Myeloid Leukemia Treatments 62
- Multiple Myeloma Research and Treatments 22
- Genetics 130
- Chronic Lymphocytic Leukemia Research 93
- Myeloproliferative Neoplasms: Diagnosis and Treatment 32
- Co-authors
- Hagop M. Kantarjian (177 shared papers)Michael J. Keating (98 shared papers)Francis J. Giles (126 shared papers)Elihu H. Estey (56 shared papers)Jörge E. Cortes (74 shared papers)Susan O’Brien (74 shared papers)Deborah A. Thomas (47 shared papers)Taghi Manshouri (52 shared papers)
- Journals
- Blood (79 papers)Cancer (43 papers)Leukemia Research (29 papers)Journal of Clinical Oncology (24 papers)British Journal of Haematology (14 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Maher Albitar
336 papers receiving 19.6k citations
Maher Albitar's Hit Papers
Peers
Comparison fields: 5 of 147
- Hematology 8.4k
- Genetics 7.4k
- Pathology and Forensic Medicine 3.6k
- Oncology 3.8k
- Immunology 2.9k
Countries citing papers authored by Maher Albitar
This map shows the geographic impact of Maher Albitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher Albitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher Albitar more than expected).
Fields of papers citing papers by Maher Albitar
This network shows the impact of papers produced by Maher Albitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher Albitar. The network helps show where Maher Albitar may publish in the future.
Co-authors
The 25 scholars most cited alongside Maher Albitar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 342 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Decitabine improves patient outcomes in myelodysplastic syndromes Hit paper breakdown → | 2006 | 1151 |
| 2 | Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL Hit paper breakdown → | 2006 | 974 |
| 3 | Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy Hit paper breakdown → | 1997 | 907 |
| 4 | Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study Hit paper breakdown → | 2002 | 709 |
| 5 | Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia Hit paper breakdown → | 2005 | 705 |
| 6 | Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells Hit paper breakdown → | 2002 | 610 |
| 7 | Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Hit paper breakdown → | 2000 | 561 |
| 8 | 2005 | 401 | |
| 9 | 2005 | 347 | |
| 10 | 2004 | 338 | |
| 11 | 2001 | 334 | |
| 12 | 1999 | 283 | |
| 13 | 1999 | 280 | |
| 14 | 2006 | 264 | |
| 15 | 2002 | 261 | |
| 16 | 2009 | 247 | |
| 17 | 2006 | 239 | |
| 18 | 2009 | 234 | |
| 19 | 2017 | 232 | |
| 20 | 1993 | 230 |
About Maher Albitar
Maher Albitar is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 342 papers that have together received 20.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (93 papers), Acute Myeloid Leukemia Research (77 papers), Chronic Myeloid Leukemia Treatments (62 papers), Lymphoma Diagnosis and Treatment (48 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers), Acute Lymphoblastic Leukemia research (31 papers), Angiogenesis and VEGF in Cancer (25 papers) and Multiple Myeloma Research and Treatments (22 papers). The work is most often cited by research in Hematology (8.4k citations), Genetics (7.4k citations), Pathology and Forensic Medicine (3.6k citations), Oncology (3.8k citations) and Immunology (2.9k citations). Maher Albitar has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Hagop M. Kantarjian, Michael J. Keating, Francis J. Giles, Elihu H. Estey, Jörge E. Cortes, Susan O’Brien, Deborah A. Thomas, Taghi Manshouri, Zeev Estrov and Charles Koller. Their work appears in journals such as Blood, Cancer, Leukemia Research, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.